Oxford Asset Management’s Medtronic MDT Stock Holding History

Oxford Asset Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,191	Closed	-$287K	–	660
2025 Q1	$287K	Sell	3,191 -4,251	-57%	-$380K	0.13%	263
2024 Q4	$594K	Buy	7,442 +3,068	+70%	+$266K	0.26%	127
2024 Q3	$394K	Buy	+4,374	New	+$368K	0.33%	104
2024 Q1	–	Sell	-2,542	Closed	-$209K	–	320
2023 Q4	$209K	Buy	+2,542	New	+$194K	0.31%	136
2020 Q1	–	Sell	-28,941	Closed	-$3.28M	–	835
2019 Q4	$3.28M	Sell	28,941 -114,359	-80%	-$12.5M	0.09%	228
2019 Q3	$15.6M	Buy	143,300 +140,647	+5,301%	+$14.7M	0.37%	28
2019 Q2	$258K	Sell	2,653 -130,788	-98%	-$11.9M	0.01%	1490
2019 Q1	$12.2M	Buy	133,441 +19,942	+18%	+$1.78M	0.27%	53
2018 Q4	$10.3M	Buy	113,499 +70,403	+163%	+$6.58M	0.27%	69
2018 Q3	$4.24M	Buy	+43,096	New	+$3.98M	0.09%	277

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Oxford Asset Management's MDT Position: Q2 2025 in Review

Oxford Asset Management sold out of Medtronic (MDT) in Q2 2025, closing a stake of 3,191 shares — an estimated $287K sold.

Oxford Asset Management first reported a position in MDT in Q3 2018 and held it in 10 quarters. The position peaked at $15.6M in Q3 2019. 2,139 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

Oxford Asset Management reported no remaining Medtronic position as of Q2 2025 after selling out during the quarter.
Oxford Asset Management sold 3,191 Medtronic shares in Q2 2025, an estimated $287K.
Oxford Asset Management first reported a position in Medtronic in Q3 2018 and held it in 10 quarters.
Oxford Asset Management's Medtronic position peaked at $15.6M in Q3 2019.
2,139 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on Oxford Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.